natgillin/translations-raw huggingface dataset:
Fluconazol Cmax  0,92 (0,85-0,99)
Fluconazole Cmax  0.92 (0.85-0.99)
Fluconazol Cmin ↔ 0,93 (0,86-1,01)
Fluconazole Cmin ↔ 0.93 (0.86-1.01)
Fluconazol Cmin  0,93 (0,86-1,01)
Fluconazole Cmin  0.93 (0.86-1.01)
fluconazol eller
rifapentine as
fluconazol eller voriconazol, , der anvendes til behandling af svampeinfektioner efavirenz, der anvendes til behandling af HIV- (humant immundefektvirus) infektion
fluconazole or voriconazole, medicines to treat fungal infections efavirenz, a medicine to treat HIV (human immunodeficiency virus) infections
fluconazol eller voriconazol, der anvendes til behandling af svampeinfektioner efavirenz, der anvendes til behandling af HIV- (humant immundefektvirus) infektion
fluconazole or voriconazole, medicines to treat fungal infections, efavirenz, a medicine to treat HIV (human immunodeficiency virus) infections,
fluconazol eller voriconazol, der anvendes til behandling af svampeinfektioner efavirenz, der anvendes til behandling af HIV- (humant immundefektvirus) infektion
fluconazoleor voriconazole, medicines to treat fungal infections, efavirenz, a medicine to treat HIV (human immunodeficiency virus) infections,
fluconazol eller voriconazol, der anvendes til behandling af svampeinfektioner, efavirenz, der anvendes til behandling af HIV- (humant immundefektvirus) infektion,
fluconazole or voriconazole, medicines to treat fungal infections, efavirenz, a medicine to treat HIV (human immunodeficiency virus) infections,
fluconazol eller voriconazol, der anvendes til behandling af svampeinfektioner. efavirenz eller tenofovir, medicin der anvendes til behandling af HIV- (humant immundefektvirus) infektion
fluconazole or voriconazole, medicines to treat fungal infections, efavirenz or tenofovir, medicines to treat HIV (human immunodeficiency virus) infections,
fluconazol eller voriconazol,der anvendes til behandling af svampeinfektioner efavirenz, der anvendes til behandling af HIV- (humant immundefektvirus) infektion
fluconazole or voriconazole, medicines to treat fungal infections, efavirenz, a medicine to treat HIV (human immunodeficiency virus) infections,
fluconazol of voriconazol, geneesmiddelen die gebruikt worden om schimmelinfecties te behandelen, efavirenz, een geneesmiddel om HIV (humaan immunodeficiëntievirus) te behandelen,
fluconazole or voriconazole, medicines to treat fungal infections, efavirenz, a medicine to treat HIV (human immunodeficiency virus) infections,
Fluconazol og andre hæmmere af både CYP2C9 og CYP3A4: Samtidig administration af fluconazol, som hovedsagligt hæmmer CYP2C9, men også i en vis udstrækning CYP3A4, kan medføre store forøgelser af plasmakoncentrationerne af bosentan.
Fluconazole and other inhibitors of both CYP2C9 and CYP3A4: Concomitant administration with fluconazole, which inhibits mainly CYP2C9, but to some extent also CYP3A4, could lead to large increases in plasma concentrations of bosentan.
fluconazol og flucytosin mod svampeinfektioner som candida.
fluconazole or flucytosine, to treat fungal infections such as candida pentamidine or atovaquone to treat parasitic infections such as PCP
Fluconazol Posaconazol
Fluconazole Posaconazole
fluconazol – anvendes mod svampeinfektioner
fluconazole - used for fungal infections
Fluconazol – anvendes mod svampeinfektioner
Fluconazole – used for fungal infections
fluconazol – til behandling af svampeinfektioner
fluconazole – to treat fungal infections
Fluconazol ↔
Fluconazole doses
Fluconazol ↔
Fluconazole ↔
fluconazol ↔ LUM Ingen dosisjustering af lumacaftor/ivacaftor
No dose adjustment of lumacaftor/ivacaftor
fluconazol, anbefales det, at der
reactions is recommended if
Fluconazol, itraconazol, ketoconazol, posaconazol, voriconazol (til behandling af svampeinfektioner).
fluconazole, itraconazole, ketoconazole, posaconazole, voriconazole (medicines to treat fungal infections)
Fluconazol, itraconazol, posaconazol
Fluconazole, itraconazole, posaconazole
Fluconazol, rifampicin eller rifapentin (antibiotika, der anvendes til behandling af infektioner)
Fluconazole, rifampicin or rifapentine (antibiotics used to treat infections)
fluconazol, voriconazol, ciprofloxacin eller chloramphenicol, der anvendes til behandling af bakterie- og svampeinfektioner
fluconazole, voriconazole, ciprofloxacin, or chloramphenicol, medicines to treat bacterial and fungal infections
fluconazol, voriconazol, ciprofloxacin eller chloramphenicol, der anvendes til behandling af bakterie- og svampeinfektioner
fluconazole, voriconazole, ciprofloxacin, or chloramphenicol, medicines to treat bacterial and fungal infections,
fluconazol, voriconazol, ciprofloxacin eller chloramphenicol, der anvendes til behandling af bakterie- og svampeinfektioner,
fluconazole, voriconazole, ciprofloxacin, or chloramphenicol, medicines to treat bacterial and fungal infections
fluconazol, voriconazol, ciprofloxacin eller chloramphenicol, der anvendes til behandling af bakterie- og svampeinfektioner.
Fluconazole, voriconazole, ciprofloxacin, or chloramphenicol, medicines to treat bacterial and fungal infections.
fluconazol, voriconazol, ciprofloxacin eller chloramphenicol, lægemidler der anvendes til behandling af svampeinfektioner.
fluconazole, voriconazole, ciprofloxacin, or chloramphenicol, medicines to treat bacterial and fungal infections,
fluconazol, voriconazol, ciprofloxacin eller chloramphfenicol, der anvendes til behandling af bakterie- og svampeinfektioner,
fluconazole, voriconazole, ciprofloxacin, or chloramphenicol, medicines to treat bacterial and fungal infections,
fluconazol.
fluconazole.
Fluconazol/miconazol (saquinavir/ritonavir)
(saquinavir/ritonavir)
Fluconazol2 Itraconazol2 Posaconazol2 Voriconazol2
Fluconazole2 Itraconazole2 Posaconazole2 Voriconazole2
Fluconazoldoser
Based on theoretical considerations
Fluconazoldoser
Fluconazole doses
Fludarabin- og alemtuzumab-refraktære patienter
Patients refractory to fludarabine and alemtuzumab
FLUENZ indgives som en delt dosis i begge næsebor.
FLUENZ is administered as a divided dose in both nostrils.
Fluenz kan som al anden medicin give bivirkninger, men ikke alle får bivirkninger.
Like all medicines, Fluenz can cause side effects, although not everybody gets them.
FLUENZ MÅ IKKE INJICERES.
DO NOT INJECT FLUENZ.
Fluenz må ikke gives som indsprøjtning.
Fluenz must not be injected.
Fluenz næsespray, suspension
Fluenz nasal spray suspension
FLUENZ næsespray, suspension Influenzavaccine (levende svækket, nasal)
FLUENZ nasal spray suspension Influenza vaccine (live attenuated, nasal)
FLUENZ næsespray, suspension Influenzavaccine (levende svækket, nasal) Sæson 2013/2014
FLUENZ nasal spray suspension Influenza vaccine (live attenuated, nasal) 2013/2014 season
Fluenz Tetra er kun til nasal anvendelse.
Fluenz Tetra is for nasal use only.
Fluenz Tetra Influenzavaccine Sæson 2016/2017
Fluenz Tetra Influenza vaccine 2016/2017 season
Fluenz Tetra leveres som en 0,2 ml suspension i en nasal applikator (type 1 glas) til engangsbrug, med studs (polypropylen med overførselsventil af polyethylen), beskyttelseslåg til studsen (syntetisk gummi), stempelstang, stempelprop (butylgummi) og en klips til dosisfordeling.
Fluenz Tetra is supplied as a 0.2 ml suspension in a single-use nasal applicator (Type 1 glass), with nozzle (polypropylene with polyethylene transfer valve), nozzle tip-protector cap (synthetic rubber), plunger rod, plunger-stopper (butyl rubber), and a dose-divider clip.
Fluenz Tetra må ikke anvendes, hvis udløbsdatoen er overskredet, eller hvis beholderen ser ud til at være beskadiget, for eksempel hvis stemplet er løst eller er faldet ud af beholderen, eller hvis der er tegn på lækage.
Do not use Fluenz Tetra if the expiry date has passed or the sprayer appears damaged, for example, if the plunger is loose or displaced from the sprayer or if there are any signs of leakage.
Fluenz Tetra må ikke gives som indsprøjtning.
Fluenz Tetra must not be injected.
Fluenz Tetra må ikke injiceres.
Do not inject Fluenz Tetra.
Fluenz Tetra næsespray, suspension
Fluenz Tetra nasal spray suspension
Fluenz Tetra næsespray, suspension Influenzavaccine (levende svækket, nasal) Sæson 2016/2017
Fluenz Tetra nasal spray suspension Influenza vaccine (live attenuated, nasal) 2016/2017 season
Fluenz Tetra påvirker ikke eller kun i ubetydelig grad evnen til at køre motorkøretøj eller bruge maskiner.
Fluenz Tetra has no or negligible influence on the ability to drive and use machines.
Fluenz Tetra svarer til Fluenz (en influenzavaccine til brug i næsen, der indeholder tre stammer), bortset fra at Fluenz Tetra giver beskyttelse mod yderligere en influenzastamme.
Fluenz Tetra is identical to Fluenz (a nasal influenza vaccine containing three strains), except Fluenz Tetra provides protection against an additional influenza strain.
Fluenz Tetras data angående virkning består af 9 kontrollerede studier, som omfattede over 20.000 spædbørn, småbørn, børn og unge, udført i løbet af 7 influenzasæsoner.
Fluenz’s efficacy data in the paediatric population consist of 9 controlled studies comprising over 20,000 infants and toddlers, children and adolescents, conducted during 7 influenza seasons.
Fluenz’ virkning
Fluenz efficacy
FLUENZ’s data angående virkning består af 9 kontrollerede studier, som omfattede over 20.000 spædbørn, småbørn, børn og unge, udført i løbet af 7 influenzasæsoner.
FLUENZ’s efficacy data in the paediatric population consist of 9 controlled studies comprising over 20,000 infants and toddlers, children and adolescents, conducted during 7 influenza seasons.
Fluktuationer er forbundet med den aftagende virkning af levodopa, der for patienten medfører pludselige skift mellem "on-perioder", hvor patienten kan bevæge sig, og "off- perioder", hvor patienten er immobil.
Fluctuations are linked to a reduction in the effects of levodopa, when the patient experiences sudden switches between being ‘on’ and able to move, and being ‘off’ and immobile.
Fluktuationer er forbundet med den aftagende virkning af levodopa, der for patienten medfører pludselige skift mellem "on-perioder", hvor patienten kan bevæge sig, og "off-perioder", hvor patienten er immobil.
Fluctuations are linked with a reduction in the effects of levodopa, when the patient experiences sudden switches between being ‘on’ and able to move, and being ‘off’ and immobile.
Fluktuationer er forbundet med den aftagende virkning af levodopa, der for patienten medfører pludselige skift mellem ”on-perioder”, hvor patienten er i stand til at bevæge sig, og ”off- perioder”, hvor patienten har vanskeligt ved at bevæge sig.
They are linked with a reduction in the effects of levodopa, when the patient experiences sudden switches between being ‘on’ and able to move, and being ‘off’ and having difficulties moving about.
Fluktuationer opstår, når lægemidlets virkning aftager, og symptomerne vender tilbage.
Fluctuations happen when the effects of the medication wear off and symptoms re- emerge.
Fluktuationsindekset (FI), som er et mål for den relative forskel mellem højeste og laveste koncentration ((Cmax-Cmin)/Cavg), var 0,58 for Prometax
The fluctuation index (FI), a measure of the relative difference between peak and trough concentrations ((Cmax-Cmin)/Cavg), was 0.58 for Prometax 4.6 mg/24 h transdermal patches, 0.77 for Prometax
Fluor vaginalis
Premenstrual syndrome
Fluorokinoloner kan passere moderkagen og kan udskilles i mælken.
Fluoroquinolones are known to cross the placenta and to be distributed into milk.
fluoropyrimidin/irinotecan- eller fluoropyrimidin/oxaliplatin- baseret kemoterapi
fluoropyrimidine/irinotecan or fluoropyrimidine/oxaliplatin based chemotherapy
Fluoroquinoloner (f.eks. moxifloxacin, sparfloxacin).
fluoroquinolones (e.g. moxifloxacin, sparfloxacin),
Fluoroquinoloner bør forbeholdes behandling af kliniske tilstande, som har responderet dårligt eller forventes at respondere dårligt på andre grupper af antibiotika.
It is prudent to reserve the fluoroquinolones for the treatment of clinical conditions that have responded poorly, or are expected to respond poorly, to other classes of antibiotic.
Fluoroquinoloner udøver deres baktericide virkning over for både replikerende og hvilende mikroorganismer.
The fluoroquinolones exert their antibacterial effects against both replicating and dormant micro- organisms.
Fluoroquinolonerne bør forbeholdes behandling af kliniske tilstande, som har responderet dårligt eller forventes at respondere dårligt på andre grupper af antibiotika.
It is prudent to reserve the fluoroquinolones for the treatment of clinical conditions that have responded poorly, or are expected to respond poorly, to other classes of antibiotic.
Fluoroquinolonerne udøver deres antibakterielle virkning både mod replicerende og hvilende mikroorganismer.
The fluoroquinolones exert their antibacterial effect against both replicating and dormant micro- organisms.
Fluoroquinolonerne udøver deres baktericide virkning over for både replikerende og hvilende mikroorganismer.
The fluoroquinolones exert their antibacterial effects against both replicating and dormant micro- organisms.
Fluorquinoloner bør ikke anvendes i kombination med nonsteroide antiinflammatoriske lægemidler (NSAID’s) til hunde, der tidligere har haft krampe.
Fluoroquinolones should not be used in combination with non-steroidal anti-inflammatory drugs (NSAIDs) in dogs with a history of seizures.
Fluorquinoloner bør ikke anvendes i kombination med nonsteroide antiinflammatoriske lægemidler (NSAID’s) til hunde, med en anamnese om krampeanfald.
Fluoroquinolones should not be used in combination with non-steroidal anti-inflammatory drugs (NSAIDs) in dogs with a history of seizures.
Fluorquinoloner udøver deres antibakterielle virkning over for både replikkerende og hvilende mikroorganismer.
The fluoroquinolones exert their antibacterial effect against both replicating and non-replicating micro-organisms.
fluoxetin (anvendes til behandling af depression),
fluoxetine (used to treat depression),
Fluoxetin (som hydroklorid).
Fluoxetine (as hydrochloride)
Fluoxetin - til behandling af depression.
Fluoxetine – for depression.
fluoxetin allupurinol sympatolytika cyclo-, tro- og iphosphamider
fluoxetine, allopurinol, sympatholytics, cyclo-, tro-and iphosphamides,
Fluoxetin metaboliseres til norfluoxetin, en ækvipotent SSRI, der medvirker til veterinærlægemidlets virkning.
Fluoxetine is metabolised to norfluoxetine, an equipotent SSRI that contributes to the efficacy the veterinary medicinal product.
fluoxetin, fluvoxamin eller moclobemid, medicin der anvendes mod depression
fluoxetine, fluvoxamine, or moclobemide, medicines to treat depression
fluoxetin, fluvoxamin eller moclobemid, medicin der anvendes mod depression
fluoxetine, fluvoxamine, or moclobemide, medicines to treat depression,
fluoxetin, fluvoxamin eller moclobemid, medicin der anvendes mod depression,
fluoxetine, fluvoxamine, or moclobemide, medicines to treat depression,
fluoxetin, fluvoxamin eller moclobemid, medicin mod depression.
fluoxetine, fluvoxamine, or moclobemide, medicines to treat depression,
fluoxetin, paroxetin, sertralin, imipramin, clomipramin (antidepressive midler),
fluoxetine, paroxetine, sertraline, imipramine, clomipramine (antidepressants),
Fluoxetin/efavirenz
Implant: Etonogestrel/efavirenz
Fluralaner dræber lopper og flåter, der har indtaget hundens eller kattens blod, ved at indvirke på deres nervesystem.
Fluralaner kills fleas and ticks that have ingested the dog’s or cat’s blood by acting on their nervous system.
Fluralaner dræber lopperne, før de kan lægge æg, og nedsætter derved forekomsten af smitte til hundens eller kattens omgivelser.
Fluralaner kills fleas before they can lay eggs and so helps to reduce contamination of the dogs’ or cats’ environment.
Fluralaner har en høj bindingsgrad til plasmaproteiner og kan konkurrere med andre stærkt bundne lægemidler såsom non-steroide anti-inflammatoriske (NSAID) præparater, og coumarinderivatet warfarin.
Fluralaner is highly bound to plasma proteins and might compete with other highly bound drugs such as non-steroidal anti-inflammatory drugs (NSAIDs) and the cumarin derivative warfarin.
Fluralaner har en høj bindingsgrad til plasmaproteiner og kan muligvis konkurrere med andre stærkt bundne lægemidler såsom non-steroide anti-inflammatoriske (NSAID) præparater og kumarinderivatet warfarin.
Fluralaner is highly bound to plasma proteins and might compete with other highly bound medicinal products such as non-steroidal anti-inflammatory drugs (NSAIDs) and the coumarin derivative warfarin.
Flushing er mest fremtrædende i hovedet, på halsen og den øverste del af kroppen.
Flushing is most prominent in the head,
Flushing fremkaldt af nikotinsyre menes at opstå som følge af frigivelsen af et stof kaldet "prostaglandin D2" (PGD2) fra hudcellerne, hvilket udvider blodkarrene i huden.
Flushing due to nicotinic acid is thought to occur because of the release of a substance called ‘prostaglandin D2’ (PGD2) from cells in the skin, which dilates (widens) the blood vessels in the skin.
Flushing var almindeligst host patienter med GIST, og blødning (hæmatom og blødning) var almindeligst hos patienter med GIST og med transformeret CML (CML-AP og CML-BC).
Flushing was most common in GIST patients and bleeding (haematoma, haemorrhage) was most common in patients with GIST and in patients with transformed CML (CML-AP and CML-BC).
Flushing var almindeligst host patienter med GIST, og blødning (hæmatom og blødning) var almindeligst hos patienter med GIST og med transformeret CML (CML-AP og CML-BC).
Flushing was most common in GIST patients and bleeding (haematoma, haemorrhage) was most common in patients with GIST and with transformed CML (CML-AP and CML-BC).
Flushing, dyb venøs trombose
Flushing, deep vein thrombosis
flushing, flebit
flushing, phlebitis
Flushing, tromboflebit (overvejende tromboflebit på infusionsstedet)
flushing, thrombophlebitis (predominantly, infusion-site thrombophlebitis)
flushing, vaskulitis, lungeemboli
Flushing, vasculitis, pulmonary embolism
Flushing‡
flushing
Flutemetamol (18F) elimineres hurtigt fra cirkulationen (via tarmen og urinvejene).
Flutemetamol (18F) is rapidly cleared from circulation (through the intestinal and urinary tracts).
Fluticason
↑Fluticasone
fluticason (medicin mod astma)
fluticasone (used to treat asthma)
Fluticason (mod høfeber)
Fluticasone (for hay fever)
Fluticason Budesonid
Fluticasone Budesonide
fluticason, et lægemiddel, der anvendes til at behandle høfeber og astma
fluticasone, a medicine used to treat hay fever and asthma
Fluticason- furoat/ vilanterol 92/22 (n=403)
fluticasone furoate/ vilanterol 92/22 (n=403)
Fluticason- furoat/ vilanterol 92/22 (n=806)
fluticasone furoate/ vilanterol 92/22 (n=806)
fluticasonfuroat
Avamys fluticasone furoate
Fluticasonfuroat / vilanterol
Fluticasone furoate / vilanterol
Fluticasonfuroat er et syntetisk trifluorineret kortikosteroid med meget høj affinitet for kortikosteroid- receptoren og potent antiinflammatorisk virkning.
Fluticasone furoate is a synthetic trifluorinated corticosteroid that possesses a very high affinity for the glucocorticoid receptor and has a potent anti-inflammatory action.
Fluticasonfuroat næsespray 110 mikrogram 1 gang daglig forbedrede signifikant nasalsymptomerne og patienternes opfattelse af det samlede behandlingsrespons sammenlignet med placebo i tre kliniske forsøg.
Fluticasone furoate nasal spray 110 micrograms once daily significantly improved nasal symptoms as well as patients’ perception of overall response to therapy compared to placebo in three studies.
Fluticasonfuroat næsespray 110 mikrogram 1 gang daglig forbedrede signifikant nasalsymptomerne og patienternes opfattelse af det samlede behandlingsrespons sammenlignet med placebo i tre kliniske studier.
Fluticasone furoate nasal spray 110 micrograms once daily significantly improved nasal symptoms as well as patients’ perception of overall response to therapy compared to placebo in three studies.
Fluticasonfuroat næsespray 110 mikrogram 1 gang daglig forbedrede signifikant øjensymptomerne og patienternes sygdomsrelaterede livskvalitet (RQLQ) sammenlignet med placebo i et klinisk forsøg.
Fluticasone furoate nasal spray 110 micrograms once daily significantly improved ocular symptoms as well as improving patients’ disease-related quality of life (RQLQ) compared to placebo in one study.
Fluticasonfuroat næsespray 110 mikrogram 1 gang daglig forbedrede signifikant øjensymptomerne og patienternes sygdomsrelaterede livskvalitet (RQLQ) sammenlignet med placebo i et klinisk studie.
Fluticasone furoate nasal spray 110 micrograms once daily significantly improved ocular symptoms as well as improving patients’ disease-related quality of life (RQLQ) compared to placebo in one study.
Fluticasonfuroat næsespray forbedrede signifikant både patienternes opfattelse af det samlede behandlingsrespons og deres sygdomsrelaterede livskvalitet (”Rhinoconjunctivitis Quality of Life Questionnaire – RQLQ") i alle fire kliniske forsøg.
Fluticasone furoate nasal spray significantly improved the patients’ perception of overall response to therapy, and the patients’ disease-related quality of life (Rhinoconjunctivitis Quality of Life Questionnaire – RQLQ), in all 4 studies.
Fluticasonfuroat tilhører gruppen af binyrebarkhormoner, der er antiinflammatoriske lægemidler.
Fluticasone furoate belongs to a group of anti- inflammatory medicines known as corticosteroids.
Fluticasonfuroat/vilanterol
Fluticasone furoate / vilanterol
fluticasonfuroat/vilanterol
Fluticasone furoate/vilanterol
Fluticasonfuroat/vilanterol 92/22 mikrogram udviste konsekvent forbedringer på 83 ml til 95 ml i trough-FEV1 ved uge 12, 36 og 52 og endepunktet sammenlignet med FF 92 mikrogram (p< 0,001; 95 % konfidensinterval 52;126 ml ved endepunktet).
Fluticasone furoate/vilanterol 92/22 micrograms consistently demonstrated 83 mL to 95 mL improvements in trough FEV1 at weeks 12, 36 and 52 and Endpoint compared with FF 92 micrograms (p<0.001 95% CI 52, 126 mL at Endpoint).
Fluticasonfuroat/vilanterol bør derfor anvendes med forsigtighed hos patienter med svær kardiovaskulær sygdom eller hjerterytmeforstyrrelser, tyreotoksikose, ukorrigeret hypokaliæmi og hos patienter disponeret for lave serumkaliumniveauer.
Therefore fluticasone furoate/vilanterol should be used with caution in patients with severe cardiovascular disease or heart rhythm abnormalities, thyrotoxicosis, uncorrected hypokalaemia or patients predisposed to low levels of serum potassium.
Fluticasonpropionat
Antimycobacterials
Fluticasonpropionat
Fluticasone propionate
Fluticasonpropionat
Fluticasone propionate: 
Fluticasonpropionat intranasalt 50 µg 4 gange dagligt i 7 dage (ritonavir 100 mg kapsler 2 gange dagligt)
Fluticasone propionate intranasal 50 µg 4 times daily for 7 days (ritonavir 100 mg capsules twice daily)
Fluticasonpropionat kan forårsage hæshed og candidiasis i mund og svælg og sjældent i øsofagus hos nogle patienter.
Due to the fluticasone propionate component, hoarseness and candidiasis (thrush) of the mouth and throat and, rarely, of the oesophagus, can occur in some patients.
Fluticasonpropionat tilhører en gruppe lægemidler, der kaldes kortikosteroider (binyrebarkhormon), der nedsætter hævelse og irritation i lungerne.
Fluticasone propionate is a corticosteroid which reduces swelling and irritation in the lungs.
Fluticasonpropionat ↑
aquinavir toxicity recommended
Fluticasonpropionat,
Fluticasone propionate,
Fluticasonpropionat,
Salmeterol
Fluticasonpropionat:
Salmeterol:
Fluticasonpropionat: 
The effects of high
fluticasonpropionat; dette kan
Fluticasone propionate:
Fluvastatin (anvendes til at behandle højt kolesterol),
fluvastatin (used to treat high cholesterol),
Fluvastatin eller
Opioids
Fluvastatin metaboliseres delvist af CYP2C9.
induction of bupropion
Fluvastatin og
Fluvastatin, and rosuvastatin are
fluvastatin og pitavastatin
fluvastatin and pitavastatin
Fluvastatin, pravastatin:
Buprenorphine, 16 mg QD
Fluvastatin-, lovastatin- eller
The dose of fluvastatin, lovastatin, or
Fluvoxamin (100 mg én gang daglig), en potent CYP1A2-hæmmer, mindskede den tilsyneladende plasmaclearance af duloxetin med omtrent 77 % og øgede AUC0-t 6 gange.
Fluvoxamine (100 mg once daily), a potent inhibitor of CYP1A2, decreased the apparent plasma clearance of duloxetine by about 77% and increased AUC0-t 6-fold.